tradingkey.logo

CeriBell Inc

CBLL
21.420USD
+0.130+0.61%
收盘 12/24, 13:00美东报价延迟15分钟
793.58M总市值
亏损市盈率 TTM

CeriBell Inc

21.420
+0.130+0.61%

关于 CeriBell Inc 公司

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc简介

公司代码CBLL
公司名称CeriBell Inc
上市日期Oct 11, 2024
CEOChao (Xingjuan)
员工数量281
证券类型Ordinary Share
年结日Oct 11
公司地址360 N. Pastoria Avenue
城市SUNNYVALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94085
电话18004360826
网址https://ceribell.com/
公司代码CBLL
上市日期Oct 11, 2024
CEOChao (Xingjuan)

CeriBell Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Ms. Erica J. Rogers
Ms. Erica J. Rogers
Director
Director
--
--
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
--
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
业务USD
名称
营收
占比
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
其他
58.67%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
其他
58.67%
股东类型
持股股东
占比
Investment Advisor
39.88%
Investment Advisor/Hedge Fund
17.92%
Private Equity
10.70%
Individual Investor
10.53%
Venture Capital
6.71%
Hedge Fund
4.45%
Research Firm
1.48%
Pension Fund
0.36%
Bank and Trust
0.22%
其他
7.75%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
4.69M
12.79%
-62.59K
-1.32%
Jun 30, 2025
TPG Capital, L.P.
3.97M
10.82%
--
--
Jun 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.75%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.46%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.02%
--
--
Jun 30, 2025
Parvizi (Josef)
2.09M
5.7%
+6.62K
+0.32%
Apr 11, 2025
Ally Bridge Group (HK) Limited
2.44M
6.66%
+265.06K
+12.18%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
3.74%
+587.42K
+75.05%
Jun 30, 2025
The Vanguard Group, Inc.
1.33M
3.61%
+631.24K
+90.98%
Jun 30, 2025
Chao (Xingjuan)
1.10M
3%
-2.89K
-0.26%
Aug 25, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
占比0.57%
Hypatia Women CEO ETF
占比0.5%
Fidelity Fundamental Small-Mid Cap ETF
占比0.1%
iShares Micro-Cap ETF
占比0.06%
ProShares Hedge Replication ETF
占比0.02%
iShares Russell 2000 Growth ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

CeriBell Inc的前五大股东是谁?

CeriBell Inc 的前五大股东如下:
Fidelity Management & Research Company LLC持有股份:4.69M,占总股份比例:12.79%。
TPG Capital, L.P.持有股份:3.97M,占总股份比例:10.82%。
Longitude Capital Management Co., LLC持有股份:2.48M,占总股份比例:6.75%。
Global Value Investment Portfolio Management Pte. Ltd.持有股份:2.37M,占总股份比例:6.46%。
Red Tree Management, LLC持有股份:2.21M,占总股份比例:6.02%。

CeriBell Inc的前三大股东类型是什么?

CeriBell Inc 的前三大股东类型分别是:
Fidelity Management & Research Company LLC
TPG Capital, L.P.
Longitude Capital Management Co., LLC

有多少机构持有CeriBell Inc(CBLL)的股份?

截至2025Q4,共有202家机构持有CeriBell Inc的股份,合计持有的股份价值约为30.92M,占公司总股份的84.91%。与2025Q3相比,机构持股有所增加,增幅为-0.12%。

哪个业务部门对CeriBell Inc的收入贡献最大?

在FY2025Q2,EEG recorders and EEG headbands, point in time业务部门对CeriBell Inc的收入贡献最大,创收15.92M,占总收入的75.11%。
KeyAI